Synonyms: FHD286
Compound class:
Synthetic organic
Comment: FHD-286 is a first-in-class oral allosteric BAF complex inhibitor. It targets the SMARCA4 (BRG1) subunit of the complex. FHD-286 was developed by Foghorn Therapeutics, and its chemical structure was disclosed at the AACR spring meeting in 2022.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[(2S)-1-[[4-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-2-yl]-1,3-thiazol-2-yl]amino]-3-methoxy-1-oxopropan-2-yl]-1-methylsulfonylpyrrole-3-carboxamide |
Synonyms ![]() |
FHD286 |
Database Links ![]() |
|
GtoPdb PubChem SID | 464244108 |
PubChem CID | 156818030 |
Search Google for chemical match using the InChIKey | JBLQNFBXKOAIHG-FCEWJHQRSA-N |
Search Google for chemicals with the same backbone | JBLQNFBXKOAIHG |
UniChem Compound Search for chemical match using the InChIKey | JBLQNFBXKOAIHG-FCEWJHQRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JBLQNFBXKOAIHG-FCEWJHQRSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Camibirstat (links to external site)
Cat. No. HY-144835 |